Cargando…

Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis

BACKGROUND: Although it is well described among adults, intravenous colistin use and its associated toxicities in newborns are poorly understood. OBJECTIVES: We present our experience of efficacy and safety of intravenous colistin in the treatment of sepsis in term and preterm neonates. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serafettin Tekgunduz, Kadir, Kara, Mustafa, Caner, Ibrahim, Demirelli, Yasar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575804/ https://www.ncbi.nlm.nih.gov/pubmed/26396706 http://dx.doi.org/10.5812/ijp.453

Ejemplares similares

The Use of Low-Dose Recombinant Tissue Plasminogen Activator to Treat a Preterm Infant with an Intrauterine Spontaneous Arterial Thromboembolism
por: Demirelli, Yaşar, et al.
Publicado: (2015)

Effect of abdomen massage for prevention of feeding intolerance in preterm infants
por: Tekgündüz, Kadir Şerafettin, et al.
Publicado: (2014)

Factors that affect placental retinol transfer in preterm infants and mothers with retinol deficiency
por: TEKGÜNDÜZ, Kadir Şerafettin, et al.
Publicado: (2021)

Safety and efficacy of colistin and fluoroquinolone in neonatal persistent late-onset sepsis
por: Al-Mouqdad, Mountasser, et al.
Publicado: (2021)

Intravenous Immunoglobulin Doesn’t Decrease Mortality for Suspected or Proven Sepsis in the Neonate
por: AlOmran, Abbas
Publicado: (2013)

Factors associated with culture proven neonatal sepsis in the Ho municipality 2016
por: Aku, Fortress Yayra, et al.
Publicado: (2020)

Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates
por: Al-lawama, Manar, et al.
Publicado: (2016)

Incidence, Bacterial Profiles, And Antimicrobial Resistance Of Culture-Proven Neonatal Sepsis In South China
por: Gao, Kankan, et al.
Publicado: (2019)

Risk factors of colistin safety according to administration routes: Intravenous and aerosolized colistin
por: Min, Kyoung Lok, et al.
Publicado: (2018)

Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates
por: Değirmencioğlu, Halil, et al.
Publicado: (2019)

Epidemic Microclusters of Blood-Culture Proven Sepsis in Very-Low-Birth Weight Infants: Experience of the German Neonatal Network
por: Härtel, Christoph, et al.
Publicado: (2012)

Clinical features and antimicrobial susceptibility profiles of culture-proven neonatal sepsis in a tertiary children's hospital, 2013 to 2017
por: Li, Xiaoxia, et al.
Publicado: (2019)

The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial
Publicado: (2008)

Bacteria profiles and risk factors for proven early-onset sepsis in preterm neonates
por: Hu, Jingwen, et al.
Publicado: (2021)

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
por: Markou, Nikolaos, et al.
Publicado: (2003)

Current-proven neonatal sepsis in Indonesian tertiary neonatal intensive care unit: a hematological and microbiological profile
por: Utomo, Martono Tri, et al.
Publicado: (2021)

Efficacy of Intravenous Colistin Monotherapy Versus Colistin Combined With Meropenem in Patients With Multidrug-Resistant Infections: A Retrospective Observational Study
por: Baig, Mehwish, et al.
Publicado: (2023)

Bacteriological Profile and Predictors of Death Among Neonates With Blood Culture-Proven Sepsis in a National Hospital in Tanzania—A Retrospective Cohort Study
por: Ba-alwi, Nour Abdallah, et al.
Publicado: (2022)

Blood Culture Proven Early Onset Sepsis and Late Onset Sepsis in Very-Low-Birth-Weight Infants in Korea
por: Lee, Soon Min, et al.
Publicado: (2015)

Effects of immunotherapy on mortality in neonates with suspected or proven sepsis: a systematic review and network meta-analysis
por: Li, Yuhang, et al.
Publicado: (2019)

Bacterial isolates, antibiogram and outcomes of blood culture proven sepsis in neonates at a tertiary institution in South East Nigeria: a cross-sectional study
por: Nnamani, Kenechi O., et al.
Publicado: (2022)

Clinical Early-Onset Sepsis Is Equally Valid to Culture-Proven Sepsis in Predicting Outcome in Infants after Preterm Rupture of Membranes
por: Grill, Agnes, et al.
Publicado: (2021)

An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country
por: Jasani, Bonny, et al.
Publicado: (2016)

Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial
por: Pourheidar, Elham, et al.
Publicado: (2019)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Outcomes in meningitis‑ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta‑analysis
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Hematological Abnormalities in Culture Positive Neonatal Sepsis
por: Adane, Tiruneh, et al.
Publicado: (2022)

Survival or Safety: Balancing act with Colistin
por: Patil, Saiprasad, et al.
Publicado: (2015)

An Unusual Case of the Successful Treatment of Carbapenem-resistant Ventriculitis with Intravenous Colistin
por: Abu Bakar, Azizi, et al.
Publicado: (2020)

Intravenous and Oral Fluid Therapy in Neonatal Calves With Diarrhea or Sepsis and in Adult Cattle
por: Constable, Peter D., et al.
Publicado: (2021)

Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use
por: Rhee, Chanu, et al.
Publicado: (2020)

Prolonged antibiotic therapy increased necrotizing enterocolitis in very low birth weight infants without culture-proven sepsis
por: Zhu, Keran, et al.
Publicado: (2022)

Colistin: Lack of efficacy: case report
Publicado: (2021)

Efficacy of an intravenous colistin regimen in ventilator-associated pneumonia and bacteraemia due to multiresistant Gram-negative bacteria: preliminary results
por: Frantzeskaki, F, et al.
Publicado: (2006)

Adenovirus and “Culture-Negative Sepsis” in a Preterm Neonate
por: Moallem, Mohannad, et al.
Publicado: (2016)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Combination Treatment with Intravenous Tigecycline and Intraventricular and Intravenous Colistin in Postoperative Ventriculitis Caused by Multidrug-resistant Acinetobacter baumannii
por: Mizrahi, Cezar J, et al.
Publicado: (2019)

Toxicity after prolonged (more than four weeks) administration of intravenous colistin
por: Falagas, Matthew E, et al.
Publicado: (2005)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fjq5so64scmdvi0fp4tl9jj0f2